These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 28506805)

  • 1. HDL abnormalities in familial hypercholesterolemia: Focus on biological functions.
    Ganjali S; Momtazi AA; Banach M; Kovanen PT; Stein EA; Sahebkar A
    Prog Lipid Res; 2017 Jul; 67():16-26. PubMed ID: 28506805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HDL functionality in familial hypercholesterolemia: effects of treatment modalities and pharmacological interventions.
    Ganjali S; Momtazi-Borojeni AA; Banach M; Kovanen PT; Gotto AM; Sahebkar A
    Drug Discov Today; 2018 Jan; 23(1):171-180. PubMed ID: 28986138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transfer of lipids to high-density lipoprotein (HDL) is altered in patients with familial hypercholesterolemia.
    Martinez LR; Santos RD; Miname MH; Deus DF; Lima ES; Maranhão RC
    Metabolism; 2013 Aug; 62(8):1061-4. PubMed ID: 23540443
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Sato M; Hamasaki M; Neufeld EB; Remaley AT; Kotani K
    Ann Clin Lab Sci; 2024 May; 54(3):419-422. PubMed ID: 39048165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small, dense high-density lipoprotein 3 particles exhibit defective antioxidative and anti-inflammatory function in familial hypercholesterolemia: Partial correction by low-density lipoprotein apheresis.
    Hussein H; Saheb S; Couturier M; Atassi M; Orsoni A; Carrié A; Therond P; Chantepie S; Robillard P; Bruckert E; Chapman MJ; Kontush A
    J Clin Lipidol; 2016; 10(1):124-33. PubMed ID: 26892129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The extended abnormalities in lipoprotein metabolism in familial hypercholesterolemia: developing a new framework for future therapies.
    Ooi EM; Barrett PH; Watts GF
    Int J Cardiol; 2013 Oct; 168(3):1811-8. PubMed ID: 23907036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reverse Cholesterol Transport Dysfunction Is a Feature of Familial Hypercholesterolemia.
    Escolà-Gil JC; Rotllan N; Julve J; Blanco-Vaca F
    Curr Atheroscler Rep; 2021 Apr; 23(6):29. PubMed ID: 33914189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of probucol on antioxidant properties of HDL in patients with heterozygous familial hypercholesterolemia.
    Inagaki M; Nakagawa-Toyama Y; Nishida M; Nakatani K; Nakaoka H; Kawase M; Kawase R; Tsubakio-Yamamoto K; Masuda D; Ohama T; Matsuyama A; Ishigami M; Komuro I; Yamashita S
    J Atheroscler Thromb; 2012; 19(7):643-56. PubMed ID: 22785024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial hypercholesterolaemia: cholesterol efflux and coronary disease.
    Versmissen J; Vongpromek R; Yahya R; van der Net JB; van Vark-van der Zee L; Blommesteijn-Touw J; Wattimena D; Rietveld T; Pullinger CR; Christoffersen C; Dahlbäck B; Kane JP; Mulder M; Sijbrands EJ
    Eur J Clin Invest; 2016 Jul; 46(7):643-50. PubMed ID: 27208892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic lipase activity and high density lipoproteins in familial hypercholesterolemia: adaptational mechanisms for LDL-receptor deficient state.
    Moriguchi EH; Tamachi H; Goto Y
    Tokai J Exp Clin Med; 1990 Nov; 15(6):401-6. PubMed ID: 1966695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reverse cholesterol transport in familial hypercholesterolemia.
    Guerin M
    Curr Opin Lipidol; 2012 Aug; 23(4):377-85. PubMed ID: 22510809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atheroprotective reverse cholesterol transport pathway is defective in familial hypercholesterolemia.
    Bellanger N; Orsoni A; Julia Z; Fournier N; Frisdal E; Duchene E; Bruckert E; Carrie A; Bonnefont-Rousselot D; Pirault J; Saint-Charles F; Chapman MJ; Lesnik P; Le Goff W; Guerin M
    Arterioscler Thromb Vasc Biol; 2011 Jul; 31(7):1675-81. PubMed ID: 21527752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholesterol efflux mediators in homozygous familial hypercholesterolemia patients on low-density lipoprotein apheresis.
    Nenseter MS; Narverud I; Græsdal A; Bogsrud MP; Aukrust P; Retterstøl K; Ose L; Halvorsen B; Holven KB
    J Clin Lipidol; 2013; 7(2):109-16. PubMed ID: 23415429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactive Dicarbonyl Scavenging Effectively Reduces MPO-Mediated Oxidation of HDL and Restores PON1 Activity.
    Huang J; Yancey PG; Tao H; Borja MS; Smith LE; Kon V; Davies SS; Linton MF
    Nutrients; 2020 Jun; 12(7):. PubMed ID: 32629758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydrogen Activates ATP-Binding Cassette Transporter A1-Dependent Efflux Ex Vivo and Improves High-Density Lipoprotein Function in Patients With Hypercholesterolemia: A Double-Blinded, Randomized, and Placebo-Controlled Trial.
    Song G; Lin Q; Zhao H; Liu M; Ye F; Sun Y; Yu Y; Guo S; Jiao P; Wu Y; Ding G; Xiao Q; Qin S
    J Clin Endocrinol Metab; 2015 Jul; 100(7):2724-33. PubMed ID: 25978109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association Between Cholesterol Efflux Capacity and Atherosclerotic Cardiovascular Disease in Patients With Familial Hypercholesterolemia.
    Ogura M; Hori M; Harada-Shiba M
    Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):181-8. PubMed ID: 26543100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive lipid and metabolite profiling of children with and without familial hypercholesterolemia: A cross-sectional study.
    Christensen JJ; Ulven SM; Retterstøl K; Narverud I; Bogsrud MP; Henriksen T; Bollerslev J; Halvorsen B; Aukrust P; Holven KB
    Atherosclerosis; 2017 Nov; 266():48-57. PubMed ID: 28963918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-density lipoprotein metabolism in familial hypercholesterolaemia: significance, mechanisms, therapy.
    Watts GF; Barrett PH
    Nutr Metab Cardiovasc Dis; 2002 Feb; 12(1):36-41. PubMed ID: 12125229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-density lipoprotein-associated sphingosine-1-phosphate activity in heterozygous familial hypercholesterolaemia.
    Frias MA; Thomas A; Brulhart-Meynet MC; Kövamees O; Pernow J; Eriksson M; Angelin B; James RW; Brinck JW
    Eur J Clin Invest; 2017 Jan; 47(1):38-43. PubMed ID: 27861771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced apolipoprotein E-rich high-density lipoprotein level at birth is restored to the normal range in patients with familial hypercholesterolemia in the first year of life.
    Nagasaka H; Miida T; Hirano K; Ota A; Yorifuji T; Takatani T; Tsukahara H; Takayanagi M; Hui SP; Kobayashi K; Chiba H
    J Clin Endocrinol Metab; 2008 Mar; 93(3):779-83. PubMed ID: 18182454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.